{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:25:53Z","timestamp":1771464353170,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T00:00:00Z","timestamp":1201737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2003<\/jats:bold> Different formulations of botulinum toxin type A (BoNTA) are not identical and may behave differently in clinical practice. The reportedly lower incidence of adverse effects with one formulation (from Allergan, Ltd.) relative to another (from Ipsen, Ltd.) may be due to differences in the degree of migration of the neurotoxin\u2013protein complex from its injection site. A double\u2010blind, randomized, within\u2010subject pilot study was performed to compare the migration characteristics of each formulation.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Twelve healthy volunteers were randomly assigned to receive three 0.1\u00a0mL intradermal injections in their forehead: 4 U BoNTA (Allergan) on one side, 12 U BoNTA (Ipsen) on the contralateral side, and saline in the center. At day 14, Minor's iodine starch test was performed, and the subjects walked around a hot room to induce sweating. The appearance of each forehead was documented using Canfield photography and the area of each anhidrotic halo calculated using software.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> Overall, the area of anhidrosis was significantly larger with BoNTA (Ipsen) than BoNTA (Allergan) \u2013 mean \u00b1 SD of 2.7\u00a0\u00b1\u00a00.78\u00a0cm<jats:sup>2<\/jats:sup> vs. 1.8\u00a0\u00b1\u00a00.65\u00a0cm<jats:sup>2<\/jats:sup> (<jats:italic>P\u00a0=<\/jats:italic>\u00a00.005) \u2013 with the area of anhidrosis being greater with BoNTA (Ipsen) than BoNTA (Allergan) in 11 of the 12 subjects. Across all subjects, the area of anhidrosis was greater with BoNTA (Ipsen) than BoNTA (Allergan) by a mean of 77%.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> BoNTA (Ipsen) migrates more than BoNTA (Allergan) under the conditions described. The lower potential of BoNTA (Allergan) to migrate promotes more precise localization of clinical effects, thereby helping to optimize the risk\/benefit ratio.<\/jats:p>","DOI":"10.1111\/j.1473-2165.2008.00361.x","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T17:59:06Z","timestamp":1201802346000},"page":"50-54","source":"Crossref","is-referenced-by-count":46,"title":["Different formulations of botulinum toxin type A have different migration characteristics: a double\u2010blind, randomized study"],"prefix":"10.1111","volume":"7","author":[{"given":"Sandeep H","family":"Cliff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harryono","family":"Judodihardjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Eltringham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,31]]},"reference":[{"key":"e_1_2_7_2_2","unstructured":"Botox\u00aePrescribing Information. Accessed June 6 2006 fromhttp:\/\/emc.medicines.org.uk\/emc\/assets\/c\/html\/displaydoc.asp?documentid=112."},{"key":"e_1_2_7_3_2","unstructured":"Dysport\u00aePrescribing Information. Accessed June 6 2006 fromhttp:\/\/emc.medicines.org.uk\/emc\/assets\/c\/html\/displaydoc.asp?documentid=870."},{"key":"e_1_2_7_4_2","unstructured":"SmutsJA De BoulleK Van CollerR BarnardPWA.An electrophysiological study to demonstrate in vivo differences between two types of botulinum toxin type A (BOTOX\u00ae and DYSPORT\u00ae). Poster presented at the 8th International Congress of Parkinson's Disease and Movement Disorder June 13\u201317 2004 Rome Italy."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.006"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32330.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870090106"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.6.10.1383"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.11.1351"},{"issue":"1","key":"e_1_2_7_10_2","first-page":"A212","article-title":"Comparison of the therapeutic windows of different botulinum neurotoxin preparations in an animal model","volume":"60","author":"Aoki R","year":"2003","journal-title":"Neurology"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000048297"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00941758"},{"key":"e_1_2_7_13_2","first-page":"459","article-title":"Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia","volume":"72","author":"Ranoux D","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199712060-00009"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033936"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05620.x"},{"key":"e_1_2_7_17_2","unstructured":"RocheN SchnitzlerA Gen\u00eatFet\u00a0al.Uncontrolled migration outside the targeted muscle associated with adverse effect of botulinum toxin type A distant from the injection site: a preliminary analysis. Poster presented at the 67th Annual Assembly of the American Academy of Physical Medicine and Rehabilitation November 11 2006: Honolulu HI."},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32331.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033931"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(01)00101-5"},{"issue":"4","key":"e_1_2_7_21_2","first-page":"10","article-title":"Using translational medicine to understand clinical differences between botulinum toxin formulations","volume":"13","author":"Aoki KR","year":"2007","journal-title":"Eur J Neurol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-447180-1.50024-9"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00839205"},{"key":"e_1_2_7_24_2","unstructured":"WardAB.Migration properties of two different botulinum toxin type A formulations in the lower\u2010middle back. Poster presented at the 67th Annual Assembly of the American Academy of Physical Medicine and Rehabilitation November 9\u201312 2006 Honolulu Hawaii USA."}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2008.00361.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1473-2165.2008.00361.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:15:41Z","timestamp":1696976141000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2008.00361.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,31]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1473-2165.2008.00361.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2008.00361.x","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,31]]}}}